Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Income (2018 - 2025)

Neurogene (NGNE) has disclosed Net Income for 5 consecutive years, with -$21.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income fell 3.15% year-over-year to -$21.0 million, compared with a TTM value of -$86.2 million through Sep 2025, down 47.85%, and an annual FY2024 reading of -$74.1 million, down 40.81% over the prior year.
  • Net Income was -$21.0 million for Q3 2025 at Neurogene, up from -$23.2 million in the prior quarter.
  • Across five years, Net Income topped out at -$17.1 million in Q1 2024 and bottomed at -$23.2 million in Q2 2025.